Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05770570
Other study ID # 15-088A(27)
Secondary ID
Status Recruiting
Phase Phase 2
First received
Last updated
Start date December 22, 2022
Est. completion date August 11, 2026

Study information

Verified date September 2023
Source Memorial Sloan Kettering Cancer Center
Contact Jennifer Leng, MD,MPH
Phone 646-888-8057
Email lengj@mskcc.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The researchers will conduct 'Taxi ROADmAP (Realizing Optimization Around Diet And Physical activity)', which also utilizes MOST, and the same 4 obesity intervention components as in SANOS, but targets the overweight/obesity crisis in another at-risk, low socioeconomic status (SES) population, taxi and for-hire vehicle (FHV) drivers (Lyft, Uber, etc.). ROADMAP also utilizes an effectiveness- implementation hybrid type 1 design. Hybrid trials, which blend effectiveness and implementation studies, can lead to more rapid translational uptake and more effective implementation. Taxi and FHV drivers are a growing, multilingual, hard-to-reach, predominantly immigrant and minority essential worker population. There are over 750,000 licensed taxi and FHV drivers in in the U.S. and over 185,000 in New York City (NYC). They have higher rates of overweight/obese range body mass index (BMI) than New Yorkers in general (77% vs 56%) and have high rates of elevated waist circumference, sedentary behavior, poor diets, and health care services underutilization. ROADmAP will test 4 evidence- and theory-based (Social Cognitive Theory [SCT]) behavior change intervention components. We will use MOST to identify which of the 4 components contribute most significantly and cost-effectively to weight loss among NYC drivers recruited at workplace health fairs (HFs) and virtually. Objectives are to apply MOST to design an optimized version of a scalable, lifestyle intervention for taxi/FHV drivers, and then to conduct a mixed methods multistakeholder process evaluation to facilitate widespread intervention implementation.


Recruitment information / eligibility

Status Recruiting
Enrollment 1067
Est. completion date August 11, 2026
Est. primary completion date January 11, 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria: For COMIDA participants only: - Self-Identifies as Mexican American or Mexican - Seeking services at the VDS of the Mexican Consulate - Prefers to speak in Spanish - All adults at least 18 years of age - Screens as obese (an adult who has a Body Mass Index (BMI) 30 or higher) or overweight (an adult who has a BMI between 25 - 29.9) - Agrees to be audio recorded For SANOS focus group participants only: - Self-identifies as Hispanic/Latino; - Seeking services at VDS or VDS Mobile; - Prefers to speak in Spanish; - At least 18 years of age; - Screens as obese (BMI = 30 kg/m^2) or overweight (BMI of 25 - 29.9 kg/m^2); - Agrees to be audio recorded For SANOS RCT participants only: - Self-identifies as Hispanic/Latino; - Seeking services at VDS or VDS Mobile; - Prefers to speak in Spanish; - At least 18 years of age; - Screens as obese (BMI = 30 kg/m^2) or overweight (BMI of 25 - 29.9 kg/m^2); - Owns a cell phone capable of receiving text messages; - Agrees to be audio recorded For Family COMIDA participants only: - Self-Identifies as Hispanic/Latino - Seeking services at the VDS (or has used VDS services in the past) of the Mexican - Consulate or VDS Mobile - Prefers to speak in Spanish - At least 18 years of age - Has at least one child under age 18 living in the same household - Owns a cell phone capable of receiving text messages - Willing to receive text messages (3 texts per week for 3 months) - Owns an internet connected device (eg, cell phone, tablet, etc) capable of conducting teleconference calls (eg, Zoom) For ROADmAP RCT participants only: - At least 21 years of age - Full-time (drives at least 35 hours per week) licensed taxi/FHV driver - Driver for at least 6 months - Seeking Health Fairs (or has used Health Fairs services in the past) - Speaks English, French, Bengali, or Spanish - Screens a as obese (BMI = 30 kg/m2 [=25 kg/m2 for South Asians]) or overweight (BMI of 25 - 29.9 kg/m2 s [23- 24.9 kg/m2 for South Asians]) - (BMI cut-offs are lower for South Asians, per WHO and American Diabetes Association recommendations) - Owns a cell phone capable of receiving text messages - Agrees to be audio-recorded For ROADmAP Phase 2 participants only: - At least 21 years of age - Driver who participated in ROADmAP RCT or manager at a taxi garage, Uber, Lyft or driver serving/union/organization - Agrees to be audio-recorded Exclusion Criteria: For COMIDA participants only: - Will not be in the NYC area for the study duration (3-4 months) Is pregnant or might be pregnant - Lactating women - Presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (Individuals with diabetes, lactose intolerance, and high blood pressure MAY still participate in the study) - Has dietary restrictions (i.e. liquid diet) - Does not have a phone that accepts text messages or unwilling to accept text messages - Presence of a serious psychiatric or cognitive impairment likely to preclude meaningful informed consent and adherence to the protocol per the consenting professional"s judgment - Has another family member already enrolled in COMIDA (as determined by patient report) For SANOS focus group participants only: - Is pregnant or might be pregnant; lactating women; - Self-reported presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with HTN and DM may still participate); - Has dietary restrictions (i.e. liquid diet); - Has a household member who has already participated (or agreed to participate); For SANOS RCT participants only: - Is pregnant or might be pregnant; lactating women; for the study duration (6 months) - Self-reported presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with HTN and DM may still participate); restricting diet; - Currently has dietary restrictions (i.e. liquid diet); - Has a household member who has already participated (or agreed to participate); - Has already participated in the study - Will not be in the NY Metropolitan area for the study duration (6 months) Works for or with the Mexican consulate (including employment and/or collaborative or volunteer services) For Family COMIDA participants only: - Is pregnant or might be pregnant; lactating women for the study duration (3 months) - Will not be in the NY Metropolitan area for the study duration (3 months) Presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (Individuals with diabetes, lactose intolerance, and high blood pressure MAY still participate in the study) - Has dietary restrictions (i.e. liquid diet) - Has another family member who has already participated in COMIDA or SANOS - Has already participated in the study - Works for or with the Mexican consulate (including employment and/or collaborative or volunteer services) For ROADmAP RCT participants only: - Is pregnant or might be pregnant; lactating women; for the study duration (12 months) - Self-reported presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with HTN and DM may still participate) that may restrict diet - Currently has dietary restrictions (i.e. liquid diet) - Has a household member who has already participated (or agreed to participate) - Has already participated in the study - Will not be in the NY Metropolitan area for 6 months from study enrollment

Study Design


Intervention

Behavioral:
Counseling
In-person individual diet and physical activity (PA) counseling
Text Messages
Thrice-weekly diet/physical activity(PA) text messages
Phone calls
Weekly telephone support
Self-monitoring tools
Self-monitoring tools

Locations

Country Name City State
United States Mexican Consulate's Ventanilla de Salud (VDS) New York New York

Sponsors (1)

Lead Sponsor Collaborator
Memorial Sloan Kettering Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Difference in participant body weight from baseline to 12 months Efficacy of intervention is achieved when participants have weight loss with a minimum threshold of 5% of overall body weight lost
Intervention components include:
Initial in-person individual diet and physical activity (PA) counseling
Thrice-weekly diet/PA text messages
Weekly telephone support
Self-monitoring tools.
12-months post-intake
Primary Estimate the cost and incremental cost-effectiveness of the obesity intervention components Costs associated with each component include: 1) In-person counseling: personnel time, participant travel time, text messaging services; 3) Telephone support: personnel time; 4) Self-monitoring tools: food diaries and digital scales. Up to 6 months
Primary Feasibility of weight loss intervention for participants measured by the ROAmAP Process Evaluation Questionnaire The ROADmAP Process Evaluation Questionnaire will be administered to all participants to gather data on implementation potential. Questions are on a Likert scale and will collect intervention delivery facilitators and barriers, intervention sustainability facilitators and barriers post-study completion. Feasibility will be indicated by extreme Likert scores (Strongly Agree, Neutral, Strongly Disagree). Up to 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2